Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Telitacicept”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Testing effectiveness (Phase 2)Ended earlyNCT04905212
What this trial is testing

Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
RemeGen Co., Ltd. 15
Not applicableStudy completedNCT07031674
What this trial is testing

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Who this might be right for
Lupus NephritisBelimumab
Yipeng Liu 56
Large-scale testing (Phase 3)Study completedNCT05673993
What this trial is testing

Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome

Who this might be right for
Primary Sjogren's Syndrome
RemeGen Co., Ltd. 381
Large-scale testing (Phase 3)WithdrawnNCT06456567
What this trial is testing

Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)

Who this might be right for
Systemic Lupus Erythematosus
Vor Biopharma
Post-approval studies (Phase 4)Looking for participantsNCT07077486
What this trial is testing

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Who this might be right for
Lupus or SLEInterstitial Lung DiseaseSystemic Lupus Erythematosus
Tongji Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06656962
What this trial is testing

The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

Who this might be right for
Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Renmin Hospital of Wuhan University 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614985
What this trial is testing

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Renmin Hospital of Wuhan University 172
Not applicableNot Yet RecruitingNCT07069972
What this trial is testing

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Yipeng Liu 180
Post-approval studies (Phase 4)UnknownNCT05899907
What this trial is testing

Efficacy and Safety of Telitacicept in Early SLE

Who this might be right for
Lupus Erythematosus, Systemic
Peking Union Medical College Hospital 180
Not applicableUnknownNCT06137053
What this trial is testing

Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus

Who this might be right for
TelitaciceptSystemic Lupus ErythematosusTherapy
Yanfeng Hou 50
Large-scale testing (Phase 3)Ended earlyNCT05306574
What this trial is testing

Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)

Who this might be right for
Systemic Lupus Erythematosus
Vor Biopharma 91
Post-approval studies (Phase 4)Looking for participantsNCT06546540
What this trial is testing

The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Peking University Third Hospital 20
Early research (Phase 1)Study completedNCT05687526
What this trial is testing

Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
RemeGen Co., Ltd. 16
Not applicableLooking for participantsNCT06458972
What this trial is testing

Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Tongji Hospital 139
Post-approval studies (Phase 4)Looking for participantsNCT05965284
What this trial is testing

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

Who this might be right for
ANCA-associated VasculitisMaintenance Therapy
Chinese SLE Treatment And Research Group 40
Testing effectiveness (Phase 2)Ended earlyNCT05078710
What this trial is testing

Telitacicept in Primary APS Patients

Who this might be right for
Anti Phospholipid Syndrome
Peking Union Medical College Hospital 20
Not applicableLooking for participantsNCT07491016
What this trial is testing

Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

Who this might be right for
TelitaciceptTreatment ComplianceRheumatoid Arthritis
Zhejiang Provincial People's Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT07249632
What this trial is testing

Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

Who this might be right for
Myasthenia Gravis, Ocular
RemeGen Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT05680480
What this trial is testing

Telitacicept in Lupus Nephritis

Who this might be right for
Lupus Nephritis
RemeGen Co., Ltd. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05799287
What this trial is testing

Telitacicept for IgA Nephropathy (TELIGAN)

Who this might be right for
Primary IgA Nephropathy
RemeGen Co., Ltd. 318
Load More Results